2019.HK
Dexin China Holdings Company Limited [2019.HK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
2019.HK Stock Summary
In the News
2019.HK Financial details
Company Rating
Neutral
Market Cap
160.34M
Income
-885.06M
Revenue
23.87B
Book val./share
2.02
Cash/share
1.82
Dividend
-
Dividend %
-
Employees
1.24K
Optionable
No
Shortable
Yes
Earnings
28 Aug 2024
P/E
1.72
Forward P/E
-
PEG
-0.13
P/S
0.01
P/B
0.04
P/C
0.03
P/FCF
0.09
Quick Ratio
0.44
Current Ratio
1.26
Debt / Equity
3.46
LT Debt / Equity
0.65
-
-
EPS (TTM)
-0.31
EPS next Y
-
EPS next Q
-
EPS this Y
-93.26%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-35.95%
Revenue last 5Y
21.95%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
3%
ROC
0.04%
Gross Margin
10%
Oper. Margin
7%
Profit Margin
1%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.031-0.65
52W High
-
52W Low
-
RSI
28
Rel Volume
5.3
Avg Volume
1.66M
Volume
8.78M
Perf Week
-38.64%
Perf Month
-48.57%
Perf Quarter
-
Perf Half Y
-60.87%
-
-
-
-
Beta
0.561
-
-
Volatility
0.01%, 0.01%
Prev Close
0%
Price
0.054
Change
5.88%
2019.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 3.12 | 3.65 | 5.8 | 8.55 | 8.13 | |
| Net income per share | 0.55 | 0.87 | 0.84 | 0.88 | 0.06 | |
| Operating cash flow per share | -1.12 | -0.06 | 0.03 | 2 | 1.29 | |
| Free cash flow per share | -1.18 | -0.11 | -0.04 | 1.82 | 1.26 | |
| Cash per share | 2.89 | 3.71 | 5.49 | 6.04 | 2.68 | |
| Book value per share | 0.94 | 1.92 | 2.16 | 2.25 | 2.41 | |
| Tangible book value per share | 2.57 | 4.12 | 6.15 | 8.17 | 7.39 | |
| Share holders equity per share | 0.94 | 1.92 | 2.16 | 2.25 | 2.41 | |
| Interest debt per share | 4.79 | 5.88 | 9.87 | 11.39 | 7.84 | |
| Market cap | 6.47B | 7.4B | 6.73B | 5.89B | 1.83B | |
| Enterprise value | 11.11B | 12.84B | 18.18B | 20.14B | 15.73B | |
| P/E ratio | 4.45 | 3.28 | 2.98 | 2.48 | 11.32 | |
| Price to sales ratio | 0.79 | 0.78 | 0.43 | 0.25 | 0.08 | |
| POCF ratio | -2.19 | -43.73 | 73.88 | 1.09 | 0.52 | |
| PFCF ratio | -2.09 | -26.39 | -59.76 | 1.2 | 0.53 | |
| P/B Ratio | 2.61 | 1.48 | 1.15 | 0.97 | 0.28 | |
| PTB ratio | 2.61 | 1.48 | 1.15 | 0.97 | 0.28 | |
| EV to sales | 1.35 | 1.35 | 1.16 | 0.87 | 0.71 | |
| Enterprise value over EBITDA | 3.36 | 3.93 | 5.07 | 4.91 | 10.48 | |
| EV to operating cash flow | -3.76 | -75.9 | 199.58 | 3.73 | 4.48 | |
| EV to free cash flow | -3.59 | -45.8 | -161.44 | 4.1 | 4.57 | |
| Earnings yield | 0.22 | 0.31 | 0.34 | 0.4 | 0.09 | |
| Free cash flow yield | -0.48 | -0.04 | -0.02 | 0.83 | 1.88 | |
| Debt to equity | 4.9 | 2.99 | 4.48 | 5 | 3.23 | |
| Debt to assets | 0.24 | 0.22 | 0.27 | 0.26 | 0.19 | |
| Net debt to EBITDA | 1.4 | 1.67 | 3.2 | 3.47 | 9.26 | |
| Current ratio | 1.18 | 1.29 | 1.38 | 1.31 | 1.26 | |
| Interest coverage | 5.66 | 10.83 | 6.09 | 8.95 | 10.74 | |
| Income quality | -1.03 | -0.06 | 0.03 | 1.5 | 3.02 | |
| Dividend Yield | 0.07 | 0.04 | 0.03 | 0.05 | 0 | |
| Payout ratio | 0.32 | 0.12 | 0.1 | 0.13 | 0 | |
| Sales general and administrative to revenue | 0.06 | 0.08 | 0.05 | 0.04 | 0.04 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.05 | 0.66 | -2.24 | -0.09 | -0.02 | |
| Capex to revenue | -0.02 | -0.01 | -0.01 | -0.02 | 0 | |
| Capex to depreciation | -11.53 | -5.92 | -7.55 | -14.44 | -1.6 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 3.42 | 6.12 | 6.38 | 6.67 | 1.79 | |
| ROIC | 0.12 | 0.12 | 0.07 | 0.06 | 0.01 | |
| Return on tangible assets | 0.03 | 0.03 | 0.02 | 0.02 | 0 | |
| Graham Net | -5.63 | -7.78 | -13.4 | -16.34 | -11.27 | |
| Working capital | 6.74B | 13.29B | 23.93B | 24.7B | 20.36B | |
| Tangible asset value | 6.75B | 10.73B | 16.61B | 22.07B | 20.12B | |
| Net current asset value | 2.04B | 2.64B | 6.27B | 9.19B | 8.03B | |
| Invested capital | 4.9 | 2.99 | 4.48 | 5 | 3.23 | |
| Average receivables | 9.03B | 9.53B | 7.65B | 3.9B | 14.82B | |
| Average payables | 1.15B | 2.87B | 5.75B | 5.28B | 3.69B | |
| Average inventory | 22.86B | 32.64B | 44.1B | 57.31B | 63.91B | |
| Days sales outstanding | 373.35 | 408.71 | 108.04 | 50.1 | 436.39 | |
| Days payables outstanding | 100.97 | 244.52 | 222.79 | 68.3 | 72.9 | |
| Days of inventory on hand | 2.01K | 2.11K | 1.58K | 1.28K | 1.17K | |
| Receivables turnover | 0.98 | 0.89 | 3.38 | 7.29 | 0.84 | |
| Payables turnover | 3.62 | 1.49 | 1.64 | 5.34 | 5.01 | |
| Inventory turnover | 0.18 | 0.17 | 0.23 | 0.28 | 0.31 | |
| ROE | 0.59 | 0.45 | 0.39 | 0.39 | 0.02 | |
| Capex per share | -0.06 | -0.04 | -0.08 | -0.18 | -0.03 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.9 | 2.17 | 2.17 | 2.02 | 2.02 | |
| Net income per share | 0.14 | -0.07 | -0.07 | -0.09 | -0.09 | |
| Operating cash flow per share | 0.53 | 0.11 | 0.11 | 0.35 | 0.35 | |
| Free cash flow per share | 0.53 | 0.11 | 0.11 | 0.35 | 0.35 | |
| Cash per share | 4 | 2.66 | 2.66 | 1.82 | 1.82 | |
| Book value per share | 2.38 | 2.39 | 2.39 | 2.02 | 2.02 | |
| Tangible book value per share | 8.43 | 7.33 | 7.33 | 5.59 | 5.59 | |
| Share holders equity per share | 2.38 | 2.39 | 2.39 | 2.02 | 2.02 | |
| Interest debt per share | 8.78 | 4.32 | 8.13 | 3.63 | 7.36 | |
| Market cap | 6.27B | 3.46B | 1.84B | 1.53B | 1.06B | |
| Enterprise value | 19.39B | -3.85B | 15.74B | -3.88B | 16.44B | |
| P/E ratio | 4.23 | -4.72 | -2.51 | -1.48 | -1.02 | |
| Price to sales ratio | 1.22 | 0.58 | 0.31 | 0.26 | 0.18 | |
| POCF ratio | 4.34 | 11.13 | 5.93 | 1.45 | 1 | |
| PFCF ratio | 4.41 | 11.67 | 6.22 | 1.46 | 1.01 | |
| P/B Ratio | 0.98 | 0.53 | 0.28 | 0.25 | 0.18 | |
| PTB ratio | 0.98 | 0.53 | 0.28 | 0.25 | 0.18 | |
| EV to sales | 3.78 | -0.65 | 2.65 | -0.65 | 2.75 | |
| Enterprise value over EBITDA | 63.41 | -21.85 | 91.83 | -13.82 | 58.55 | |
| EV to operating cash flow | 13.43 | -12.38 | 50.63 | -3.69 | 15.62 | |
| EV to free cash flow | 13.64 | -12.98 | 53.08 | -3.71 | 15.69 | |
| Earnings yield | 0.06 | -0.05 | -0.1 | -0.17 | -0.25 | |
| Free cash flow yield | 0.23 | 0.09 | 0.16 | 0.68 | 0.99 | |
| Debt to equity | 3.69 | 1.81 | 3.23 | 1.79 | 3.46 | |
| Debt to assets | 0.2 | 0.11 | 0.19 | 0.11 | 0.22 | |
| Net debt to EBITDA | 42.9 | -41.49 | 81.07 | -19.28 | 54.79 | |
| Current ratio | 1.3 | 1.26 | 1.26 | 1.23 | 1.23 | |
| Interest coverage | 0 | 0 | 0.14 | 0 | 0.25 | |
| Income quality | 3.9 | -1.7 | -1.7 | -4.06 | -4.06 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.04 | 0.03 | 0.03 | 0.06 | 0.06 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.02 | -0.05 | -0.05 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.95 | 410.1 | 410.1 | -0.3 | -0.3 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 2.71 | 1.89 | 1.89 | 1.99 | 1.99 | |
| ROIC | 0.01 | -0.19 | -0.13 | -0.13 | -0.08 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | -18 | -17.18 | -11.17 | -15.62 | -15.66 | |
| Working capital | 24.45B | 20.36B | 20.36B | 15.54B | 15.54B | |
| Tangible asset value | 22.76B | 20.12B | 20.12B | 16.59B | 16.59B | |
| Net current asset value | 10.81B | 8.03B | 8.03B | 4.53B | 4.53B | |
| Invested capital | 3.69 | 1.81 | 3.23 | 1.79 | 3.46 | |
| Average receivables | 0 | 2.36B | 15.49B | 13.5B | 532.26M | |
| Average payables | 0 | 3.56B | 3.99B | 4.21B | 4.44B | |
| Average inventory | 0 | 66.47B | 64.16B | 59.04B | 53.8B | |
| Days sales outstanding | 3.72 | 68.08 | 400.52 | 8 | 8 | |
| Days payables outstanding | 62.85 | 65.3 | 65.3 | 76.48 | 76.48 | |
| Days of inventory on hand | 1.38K | 1.05K | 1.05K | 928.4 | 924.35 | |
| Receivables turnover | 24.22 | 1.32 | 0.22 | 11.24 | 11.24 | |
| Payables turnover | 1.43 | 1.38 | 1.38 | 1.18 | 1.18 | |
| Inventory turnover | 0.07 | 0.09 | 0.09 | 0.1 | 0.1 | |
| ROE | 0.06 | -0.03 | -0.03 | -0.04 | -0.04 | |
| Capex per share | -0.01 | -0.01 | -0.01 | 0 | 0 |
2019.HK Frequently Asked Questions
What is Dexin China Holdings Company Limited stock symbol ?
Dexin China Holdings Company Limited is a CN stock and trading under the symbol 2019.HK
What is Dexin China Holdings Company Limited stock quote today ?
Dexin China Holdings Company Limited stock price is $0.054 today.
Is Dexin China Holdings Company Limited stock public?
Yes, Dexin China Holdings Company Limited is a publicly traded company.
Company Profile
- Volume Average 1.66M
- Market Capitalization 160.34M
- Employee 1.24K
- CEO Mr. Yiping Hu
- Headquarters Hangzhou,CN
- IPO Date 2019-02-26
-
Website
https://www.dothinkgroup.com 
Dexin China Holdings Company Limited, an investment holding company, engages in the property development business in the People's Republic of China. The company operates through three segments: Property Development and Construction, Property Investment, and Other Businesses. It develops residential and commercial properties; and develops, operates, and manages commercial and mixed-use properties. The company is also involved in the property construction and project management activities; leasing of commercial properties; and hotel operation activities. Dexin China Holdings Company Limited was founded in 1993 and is headquartered in Hangzhou, the People's Republic of China. Dexin China Holdings Company Limited is a subsidiary of Tak Shin International Limited.
